Lifeboat Foundation

1. The 4 main things happening in Hyperbaric oxygen treatment: 1.- A decrease of inflammation 2.- An increase in the amount of oxygen in circulation and reversing hypoxia. 3.- Stimulate the release of stem cells from the brain along with the bone-derived stem cells. 4.- Kill infection. Why it matters for regenerative and dementia treatment? Listen to Dr. Scott Sherr explaining in detail in http://www.mendelhaim.com/podcast/2. For more information on Dr. Scott’s work go to https://www.hyperbaricmedicalsolutions.com/integrative-hbot/scott-sherr.

2. Raising money for academic research is a hard point, according to all of my guests, but even when we talk about Hyperbaric treatment there is a lack of money and the number of chambers declines in u.s. In Israel by the way, the demand is increasing and it takes a few months waiting in lines to start getting the treatment, this can turn into a big business opportunity in my opinion as to the risk for such research on participants is not as big as other medical research.

3. Longevity investment is a relatively new field and is lack of a method to invest by, the Three criteria that Sergey Young from the Longevity Vision Fund examine before investing in new companies are 1- will the product be affordable to touch millions of people’s lives and not only help the rich. 2- Looking for sectors that enjoy the technological exponential development paste such as AI, early diagnostics, stem cells, warbles, and organ transplants. 3 — Network, if you are a new startup and trying to raise from The Longevity vision fund, question yourself before, Do you have partners that can market your product such as big pharma or health care chain or a big manufacturer, do you collaborate with the best academic institutes in the longevity research. Go listen to the full episode Mission Alpha with Sergey Young on http://www.mendelhaim.com/podcast/3

Click on photo to start video.

Want to live a healthier, longer life? Try taking more prebiotics — also, don’t eat sometimes.

In this video, bestselling author Dave Asprey explains.

The field of cryonics — freezing the body after death to be revived in the future — is advancing with new technology and research. Now, the leading players in cryonics are gathering in South Florida to build interest and share new developments.

New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works. The findings potentially pave the way for better cancer treatments and revolutionary new drugs that could vastly improve human health in the twilight years.

The work, from Assistant Professor of Chemical Engineering and Materials Science Nick Graham and his team in collaboration with Scott Fraser, Provost Professor of Biological Sciences and Biomedical Engineering, and Pin Wang, Zohrab A. Kaprielian Fellow in Engineering, was recently published in the Journal of Biological Chemistry.

“To drink from the fountain of youth, you have to figure out where the fountain of youth is, and understand what the fountain of youth is doing,” Graham said. “We’re doing the opposite; we’re trying to study the reasons cells age, so that we might be able to design treatments for better aging.”

Being forever young has long been a dream for many. Now there are new ways to slow down the aging process. Switzerland is jumping on the trend, with a growing hub of science and economic activity around staying young. Harvard Medical School’s David Sinclair says the “fountain of youth pill” could soon become a reality.

The Life Extension Foundation is a nonprofit organization whose goal is to extend the healthy human lifespan by discovering scientific methods to control aging and eradicate disease. continue

Since its inception in 1980, the Life Extension Foundation has continued its dedication to finding new scientific methods for eradicating old age, disease and death. continue .

Are you Cryo-Curious? Learn about the real facts of cryonics at the first Cryonics Symposium International.

The mission of Cryonics Symposium International is to bring leaders in the cryonics community together to learn from each other and promote the emerging science of cryonics.

With master-of-ceremonies Rudi Hoffman, the first time ever assembly of luminaries from different cryonics organizations will be presenting on the concepts behind the science and research of cryonics at the Church of Perpetual Life in Hollywood, Florida on Saturday, July 27th from 10 AM — 5 PM. The Church is located at 1855 McKinley St, Hollywood, FL 33021. This historic event is free-of-charge: donations are graciously accepted. Attendees will enjoy complimentary meals for the duration of the event. Seats are limited. RSVP is required via Eventbrite https://www.eventbrite.com/e/cryonics-symposium-internationa…———-

Researchers have discovered a new drug that targets the mTOR pathway, which is involved in aging and metabolism. It could function as a caloric restriction mimetic, bringing about similar health benefits.

The mTOR pathway

The mechanistic target of rapamycin (mTOR) pathway is a part of metabolism and is one of the four major pathways that control it; collectively, the four pathways are affected by deregulated nutrient sensing, which is a hallmark of aging.

Recently, we had the opportunity to interview Professor George Church, a well-known geneticist and rejuvenation expert whom we have previously interviewed. Prof. Church’s company, Rejuvenate Bio, will be launching a clinical trial to test a rejuvenation therapy in dogs this fall.

In your recent paper on enabling large-scale genome editing, you talked about manipulating endogenous transposable elements with the help of dead Cas9 base editors. At Ending Age-Related Diseases, Andrei Gudkov spoke about the super mutagenic phenotype that arises from the expression of LINE1 reverse transcriptase. In this context, he mentioned the possibility of the retrobiome (as he referred to it) being the main driver of all types of cellular damage, which is consequently improperly addressed due to immunosenescence. Do you share his views on the contribution of LINEs and SINEs in aging? If not, why?

Yes. That is one of the reasons why we explored the tech for editing of repeats. We are now extending this to the germline engineering of repeats.